Perimeter Solutions, Inc. PRM

Healthcare SIC 2800 - Chemicals & Allied Products NAICS Manufacturing › Chemical Manufacturing derived NYSE

We are a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications. Our current operations span firefighting products, lubricant additives, electronic components and, following the acquisition of Medical Manufacturing Technologies, LLC ("MMT") in January 2026, highly engineered machinery for the medical device industry. We develop products that address complex customer challenges where there is little margin for error. Our offerings are typically a small part of a much broader solution that serves a growing end market. Our goal is to meet customer needs better than any alternative in every market we serve.

We aim to maximize our organic reinvestment into our business to best serve our customers and to support the rigorous application of our Operational Value Drivers: seeking out profitable new business, structurally improving operational productivity, and sharing in value creation through value-based pricing. These Operational Value Drivers are overseen by general managers that operate in our decentralized operating structure. These managers have full operational autonomy paired with accountability to deliver results for customers and stockholders, with strong alignment between compensation and results.

Last close 27.80 2026-10-23
Market cap $4.55B 2026-06-30 share count
52-week range 20.38 - 38.17

Valuation FY2025 figures against the last close

P/S7.0x
P/E—
P/FCF21.8x
EV/EBITDA—
Dividend yield—
Diluted EPS-1.37

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue $652.9M$561.0M$322.1M$360.5M—$339.6M$239.3M—
Cost of revenue $277.7M$243.9M$193.8M$231.9M—$177.5M$155.4M—
Gross profit $375.1M$317.1M$128.3M$128.7M—$162.0M$83.9M—
SG&A $77.6M$66.9M$46.5M$60.3M—$37.7M$36.2M—
Total operating expenses $576.1M$320.9M$33.8M-$1.4M—$90.6M$89.7M—
Operating income -$200.9M-$3.8M$94.5M$130.1M—$71.5M-$5.8M—
Interest expense $39.1M$40.5M$41.4M$42.6M—$42.0M$51.7M—
Pre-tax income -$236.2M-$46.9M$61.6M$97.2M—$34.7M-$59.7M—
Income tax $29.9M$41.0M$5.9M$5.5M—$10.5M$17.7M—
Net income -$206.4M-$5.9M$67.5M$91.8M-$661.5M$24.2M-$42.0M—
EPS, basic -1.37-0.040.440.57—0.46-0.79—
EPS, diluted -1.37-0.040.410.52—0.46-0.79—
Shares, diluted (wtd. avg.) 150.4M145.7M166.5M175.1M—53.0M53.0M—

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents $325.9M$198.5M$47.3M$126.8M$225.6M$22.5M$9.8M$16.0M
Short-term investments —$0$5.5M$0————
Receivables $64.4M$56.0M$39.6M$26.6M$24.3M$28.9M——
Inventory $139.6M$116.3M$145.7M$143.0M$106.9M$58.8M——
Total current assets $564.0M$394.0M$251.0M$308.5M$371.8M$133.0M——
Property, plant and equipment $85.1M$64.8M$59.4M$58.8M$62.2M$48.2M——
Goodwill $1.07B$1.03B$1.04B$1.03B$1.04B$482.0M$473.2M—
Other intangibles $899.3M$898.4M$945.0M$1.04B$1.10B$473.7M——
Total assets $2.65B$2.42B$2.32B$2.46B$2.58B$1.14B——
Accounts payable ———$43.0M$27.5M$9.9M——
Short-term debt ————$0$6.7M——
Total current liabilities $175.1M$62.5M$55.1M$74.2M$100.5M$32.9M——
Long-term debt $669.1M$667.8M$666.5M$665.3M$664.1M$680.5M——
Total liabilities $1.52B$1.26B$1.16B$1.32B$1.50B$846.8M——
Retained earnings -$793.1M-$586.7M-$580.8M-$648.3M-$738.5M-$47.8M——
Total equity $1.13B$1.16B$1.15B$1.14B$1.08B$291.4M$262.4M$314.6M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating cash flow $238.1M$188.4M$193.0K-$40.2M—$70.8M-$305.0K—
Depreciation and amortisation $14.3M$10.7M$9.8M$10.7M—$6.7M$6.9M—
Stock-based compensation $16.6M$12.8M$1.6M$14.6M—$0$0—
Capital expenditure $29.6M$15.5M$9.4M$8.6M—$7.5M$8.9M—
Investing cash flow -$106.8M-$42.9M-$14.9M-$10.3M—-$9.5M-$25.2M—
Financing cash flow -$9.0M$8.3M-$64.5M-$48.8M—-$45.6M$21.0M—
Buybacks $40.4M$14.4M$64.1M$49.3M—$0——

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001880319-26-000023.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -1B -500M 0 500M 1B Revenue, FY2019: 239.3M Gross profit, FY2019: 83.9M Net income, FY2019: -42M Revenue, FY2020: 339.6M Gross profit, FY2020: 162M Net income, FY2020: 24.2M Net income, FY2021: -661.5M Revenue, FY2022: 360.5M Gross profit, FY2022: 128.7M Net income, FY2022: 91.8M Revenue, FY2023: 322.1M Gross profit, FY2023: 128.3M Net income, FY2023: 67.5M Revenue, FY2024: 561M Gross profit, FY2024: 317.1M Net income, FY2024: -5.9M Revenue, FY2025: 652.9M Gross profit, FY2025: 375.1M Net income, FY2025: -206.4M FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue — $239.3M $339.6M — $360.5M $322.1M $561.0M $652.9M
Gross profit — $83.9M $162.0M — $128.7M $128.3M $317.1M $375.1M
Net income — -$42.0M $24.2M -$661.5M $91.8M $67.5M -$5.9M -$206.4M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Material agreement signed Item 1.01
  • Other event Item 8.01
  • Other event Item 8.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2800

TickerCompanyMarket capP/ERevenue growth
SOLS Solstice Advanced Materials Inc. $9.44B 39.9x 3.1%
BCPC BALCHEM CORP $5.64B 37.3x 8.8%
IOSP INNOSPEC INC. $2.43B 21.1x -3.7%
NGVT Ingevity Corp $2.39B — -2.7%
CC Chemours Co $1.93B — 0.4%
OLN OLIN Corp $1.78B — 3.7%
HUN Huntsman CORP $1.54B — -5.8%
ECVT Ecovyst Inc. $1.07B — 20.9%